anastrozole has been researched along with Fatty Liver in 3 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tamoxifen and anastrozole are widely used as adjuvant treatment for early stage breast cancer, but their hepatotoxicity is not fully defined." | 9.19 | A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer. ( Chen, D; Deng, Y; Feng, G; He, P; Hu, R; Huang, T; Li, E; Li, L; Li, Y; Liang, Z; Lin, Y; Liu, J; Lu, Y; Ma, R; Su, F; Sun, S; Tong, Z; Wang, S; Wang, X; Wu, Y; Xu, Z; Zhang, H; Zhang, X; Zhang, Y; Zhao, Y, 2014) |
| "Among 1203 subjects who were taking adjuvant TMX or AI (anastrozole or letrozole) without fatty liver at baseline, those taking TMX or AI were 1:1 matched on the propensity score." | 7.85 | Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study. ( Hong, N; Kim, SI; Park, S; Rhee, Y; Seo, DH; Sohn, JH; Yoon, HG, 2017) |
| "Tamoxifen and anastrozole are widely used as adjuvant treatment for early stage breast cancer, but their hepatotoxicity is not fully defined." | 5.19 | A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer. ( Chen, D; Deng, Y; Feng, G; He, P; Hu, R; Huang, T; Li, E; Li, L; Li, Y; Liang, Z; Lin, Y; Liu, J; Lu, Y; Ma, R; Su, F; Sun, S; Tong, Z; Wang, S; Wang, X; Wu, Y; Xu, Z; Zhang, H; Zhang, X; Zhang, Y; Zhao, Y, 2014) |
| "Among 1203 subjects who were taking adjuvant TMX or AI (anastrozole or letrozole) without fatty liver at baseline, those taking TMX or AI were 1:1 matched on the propensity score." | 3.85 | Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study. ( Hong, N; Kim, SI; Park, S; Rhee, Y; Seo, DH; Sohn, JH; Yoon, HG, 2017) |
| "A 48-year old woman with metastatic breast cancer and extensive bone marrow infiltration was admitted with extreme lethargy, jaundice and deranged liver function tests." | 1.40 | An unusual cause of jaundice in a patient with breast cancer. ( Evans, A; Lacey, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, N | 1 |
| Yoon, HG | 1 |
| Seo, DH | 1 |
| Park, S | 1 |
| Kim, SI | 1 |
| Sohn, JH | 1 |
| Rhee, Y | 1 |
| Lin, Y | 1 |
| Liu, J | 3 |
| Zhang, X | 1 |
| Li, L | 1 |
| Hu, R | 1 |
| Deng, Y | 1 |
| Chen, D | 1 |
| Zhao, Y | 2 |
| Sun, S | 1 |
| Ma, R | 1 |
| Zhang, Y | 1 |
| Wang, X | 2 |
| Li, Y | 1 |
| He, P | 1 |
| Li, E | 1 |
| Xu, Z | 1 |
| Wu, Y | 1 |
| Tong, Z | 1 |
| Huang, T | 1 |
| Liang, Z | 1 |
| Wang, S | 2 |
| Su, F | 1 |
| Lu, Y | 1 |
| Zhang, H | 1 |
| Feng, G | 1 |
| Lacey, R | 1 |
| Evans, A | 1 |
1 trial available for anastrozole and Fatty Liver
| Article | Year |
|---|---|
A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer.
Topics: Aged; Anastrozole; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Fatty Liver; | 2014 |
2 other studies available for anastrozole and Fatty Liver
| Article | Year |
|---|---|
Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Breast | 2017 |
An unusual cause of jaundice in a patient with breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Chemical and Drug Induced Li | 2014 |